Ditchcarbon
  • Contact
  1. Organizations
  2. Wockhardt
Public Profile
Pharmaceutical Preparation Manufacturing
IN
updated 2 months ago

Wockhardt Sustainability Profile

Company website

Wockhardt Limited, a prominent player in the global pharmaceutical industry, is headquartered in Mumbai, India. Founded in 1960, the company has established a strong presence in key operational regions, including the United States, Europe, and emerging markets. Wockhardt is renowned for its innovative approach to healthcare, focusing on biotechnology, generics, and specialty pharmaceuticals. The company’s core products encompass a diverse range of therapeutic areas, including antibiotics, vaccines, and biopharmaceuticals, distinguished by their commitment to quality and research-driven development. Wockhardt has achieved notable milestones, such as receiving multiple FDA approvals and expanding its manufacturing capabilities across the globe. With a robust market position, Wockhardt continues to contribute significantly to the healthcare landscape, driven by its dedication to improving patient outcomes and advancing medical science.

DitchCarbon Score

How does Wockhardt's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

40

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Wockhardt's score of 40 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.

59%

Let us know if this data was useful to you

Wockhardt's reported carbon emissions

In 2024, Wockhardt reported total carbon emissions of approximately 10,052,280 kg CO2e for Scope 1 and about 55,818,850 kg CO2e for Scope 2, alongside approximately 308,710 kg CO2e for Scope 3 emissions. This marks a significant reduction from 2023, where emissions were about 19,167,000 kg CO2e for Scope 1 and approximately 112,712,000 kg CO2e for Scope 2. In 2022, the figures were even higher, with Scope 1 emissions at around 32,846,000 kg CO2e and Scope 2 at about 143,853,000 kg CO2e. Wockhardt has set ambitious climate commitments, aiming for a 50% reduction in absolute emissions for both Scope 1 and Scope 2 by 2030, with the baseline year being 2021. This target reflects the company's proactive approach to addressing climate change and reducing its carbon footprint. The reduction initiatives are documented in their ESG reports, indicating a structured plan to achieve these goals. Wockhardt's emissions data is not cascaded from any parent company, and all figures are reported directly from Wockhardt Limited. The company is committed to transparency and accountability in its climate actions, aligning with industry standards for sustainability.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

202220232024
Scope 1
32,846,000
00,000,000
00,000,000
Scope 2
143,853,000
000,000,000
00,000,000
Scope 3
-
-
000,000

How Carbon Intensive is Wockhardt's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Wockhardt's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Wockhardt's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Wockhardt is in IN, which has a very high grid carbon intensity relative to other regions.

Wockhardt's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Wockhardt has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Wockhardt's Emissions with Industry Peers

Viatris

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Sandoz International GmbH

DE
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Zydus Lifesciences

IN
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Alkem Laboratories

IN
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Cipla

IN
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Glenmark Pharmaceuticals

IN
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251105.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy